Get the Stockscreener App
4.385
3.41%
-0.155
Endra Life Sciences Inc stock is traded at $4.385, with a volume of 28,182.
It is down -3.41% in the last 24 hours and down -32.54% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$4.54
Open:
$4.53
24h Volume:
28,182
Relative Volume:
0.02
Market Cap:
$3.30M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-0.00634
EPS:
-691.4213
Net Cash Flow:
$-8.08M
1W Performance:
-9.77%
1M Performance:
-32.54%
6M Performance:
+1.28%
1Y Performance:
-71.85%
1-Day Range:
$4.24
$4.53
1-Week Range:
$4.24
$4.92
52-Week Range:
$2.90
$25.90
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.385 | 3.63M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Endra Life Sciences Inc Stock (NDRA) Latest News
Using data filters to optimize entry into ENDRA Life Sciences Inc.Trade Exit Report & AI Powered Market Trend Analysis - Newser
Key resistance and support levels for ENDRA Life Sciences Inc.Weekly Stock Summary & Daily Volume Surge Signals - Newser
Long term hold vs stop loss in ENDRA Life Sciences Inc.Earnings Growth Summary & Verified Short-Term Plans - Newser
Strategies to average down on ENDRA Life Sciences Inc.Quarterly Profit Report & High Conviction Buy Zone Alerts - Newser
Using Ichimoku Cloud for ENDRA Life Sciences Inc. technicals2025 Fundamental Recap & Real-Time Market Sentiment Alerts - Newser
Will a bounce in 180 Life Sciences Corp. Equity Warrant offer an exitWeekly Trade Review & Safe Entry Momentum Stock Tips - Newser
Is It Too Late to Sell ENDRA Life Sciences Inc.Volume Spike & AI Powered Trade Plan Recommendations - 선데이타임즈
Multi asset correlation models including ENDRA Life Sciences Inc.2025 Market WrapUp & Safe Capital Growth Tips - Newser
Will ENDRA Life Sciences Inc. continue its uptrendQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - Newser
Volatility clustering patterns for Atai Life Sciences N.V.Quarterly Trade Summary & Weekly Watchlist for Consistent Profits - Newser
Technical signs of recovery in ENDRA Life Sciences Inc.Recession Risk & Low Risk Entry Point Tips - Newser
Risk adjusted return profile for ENDRA Life Sciences Inc. analyzedOil Prices & Growth Focused Stock Reports - Newser
What MACD signals say about Abrdn Life Sciences InvestorsJuly 2025 Levels & Weekly High Return Opportunities - Newser
ENDRA LIFE SCIENCES Earnings Preview: Recent $NDRA Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Is ENDRA Life Sciences Inc. Stock a Good Fit for Conservative Investors2025 Trading Recap & Real-Time Chart Pattern Alerts - Newser
Why ENDRA Life Sciences Inc. stock attracts strong analyst attentionTrade Entry Summary & Reliable Volume Spike Trade Alerts - Newser
How to monitor ENDRA Life Sciences Inc. with trend dashboardsJuly 2025 Intraday Action & AI Driven Stock Movement Reports - Newser
How ENDRA Life Sciences Inc. stock performs during market volatilityJuly 2025 Momentum & Verified Momentum Watchlists - Newser
What data driven models say about ENDRA Life Sciences Inc.’s futureTrade Risk Summary & Fast Moving Stock Watchlists - Newser
Is ENDRA Life Sciences Inc. stock reversal real or fakeTrend Reversal & Stepwise Trade Execution Plans - Newser
Should you wait for a breakout in ENDRA Life Sciences Inc.July 2025 Patterns & Precise Swing Trade Entry Alerts - Newser
Does ENDRA Life Sciences Inc. stock benefit from AI growthMarket Sentiment Report & Short-Term Swing Trade Alerts - thegnnews.com
Volatility clustering patterns for 180 Life Sciences Corp.2025 Momentum Check & Expert Curated Trade Ideas - Newser
What does recent volatility data suggest for ENDRA Life Sciences Inc.July 2025 Chart Watch & Low Drawdown Investment Ideas - Newser
Wall Street Zen Downgrades ENDRA Life Sciences (NASDAQ:NDRA) to Sell - Defense World
What makes ENDRA Life Sciences Inc. stock price move sharplyEarnings Growth Summary & Technical Pattern Based Buy Signals - Newser
Quantitative breakdown of ENDRA Life Sciences Inc. recent moveJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - Newser
ENDRA Life Sciences Inc. Company Revenue and Profit Trends: A Deep Dive2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Does ENDRA Life Sciences Inc. qualify in momentum factor screening2025 Price Targets & Safe Entry Momentum Stock Tips - Newser
Can volume confirm reversal in ENDRA Life Sciences Inc.July 2025 Price Swings & Capital Efficiency Focused Strategies - Newser
Can ENDRA Life Sciences Inc. expand its profit marginsJuly 2025 News Drivers & Weekly Setup with High ROI Potential - mustnews.co.kr
ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results - BioSpace
When is the best time to buy ENDRA Life Sciences Inc. stock2025 Growth vs Value & Real-Time Volume Triggers - Newser
Endra Life Sciences reports Q2 EPS ($1.71) vs. (8c) last year - TipRanks
ENDRA Life Sciences Advances TAEUS Liver Development, Reports Q2 2025 Financial Results with 42% Decrease in Operating Expenses. - AInvest
ENDRA's Enhanced Liver Scanner Could Transform Early Disease Detection for 2B Patients - Stock Titan
Bollinger Bands Show Potential Breakout in ENDRA Life Sciences Inc.Earnings Beat & Safe Investment Capital Preservation Plans - mustnews.co.kr
Is ENDRA Life Sciences Inc. in a bullish channelFree Stock Tracker App - thegnnews.com
What machine learning models say about ENDRA Life Sciences Inc.Free Access to Smart Investment Tips - Newser
Vanguard Extended Market ETF (VXF) Expected to Reach $233 - AInvest
What high frequency data says about ENDRA Life Sciences Inc.Entry and Exit Strategy for Swing Traders - Newser
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.05%
1.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):